US2009143759A1PendingUtilityA1
Methods, Devices, Kits and Systems for Defunctionalizing the Cystic Duct
Est. expiryNov 30, 2027(~1.4 yrs left)· nominal 20-yr term from priority
A61M 29/02A61M 2025/1072A61F 2/2493A61F 2002/041A61F 2/04A61M 27/008A61M 2025/0233A61B 2017/00278A61B 2017/1139A61F 2/064A61F 2/24A61B 17/11A61F 2250/0039A61B 17/1114A61M 25/1002A61F 2220/0008
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The application discloses devices, systems, kits and methods for treating biliary disease. Devices comprise, for example, a component configurable for deployment between within a cystic duct of a patient which has a proximal end and a distal end. In some embodiments, a lumen may also extend therethrough.
Claims
exact text as granted — not AI-modified1 . A device for treating biliary disease comprising: a component configurable for placement within a cystic duct of a biliary system of a patient which has a proximal end and a distal end.
2 . The device of claim 1 further comprising a delivery mechanism for delivering a substance.
3 . The device of claim 1 wherein the device is formed from at least one of a bioresorbable material or an activatable material.
4 . The device of claim 1 wherein the device is removable.
5 . The device of claim 1 wherein the device is expandable.
6 . The device of claim 1 further comprising one or more configurations selected from a deployment configuration, a delivery configuration and a final configuration.
7 . The device of claim 6 further comprising a variable profile.
8 . The device of claim 1 wherein a cross-sectional area of the device is variable along a length.
9 . The device of claim 1 wherein the device is configurable for deployment by an endoscope.
10 . The device of claim 1 wherein the device is configurable for deployment by a guidance element.
11 . The device of claim 1 wherein a lumen is provided that is configurable to provide restrictable fluid flow.
12 . The device of claim 10 further comprising one or more fluid control components.
13 . (canceled)
14 . (canceled)
15 . The device of claim 1 wherein the device is flexible.
16 . A biliary disease treatment device comprising:
an implant adapted to be delivered by an endoscope, guidance element to a gastrointestinal site in proximity to a gallbladder, and further adapted to form a conduit between the gastrointestinal site and the gallbladder.
17 . (canceled)
18 . (canceled)
19 . (canceled)
20 . (canceled)
21 . (canceled)
22 . (canceled)
23 . (canceled)
24 . (canceled)
25 . (canceled)
26 . (canceled)
27 . (canceled)
28 . A method of delivering a device to treat biliary disease comprising:
a. using an endoscope to place a guidance element between an access lumen and a gallbladder; b. inserting a delivery catheter over the guidance element and into the gallbladder; c. delivering a cystic duct defunctionalizing device on the guidance element; and d. positioning the cystic duct defunctionalizing device within a cystic duct.
29 . (canceled)
30 . (canceled)
31 . (canceled)
32 . (canceled)
33 . (canceled)
34 . The method of claim 28 further comprising the step of localizing the gallbladder via endoscopic ultrasound.
35 . The method of claim 28 further comprising the step of removing gallstones.
36 . The method of claim 28 further comprising the step of altering gallstones.
37 . The method of claim 36 further comprising the step of removing the altered gallstones.
38 . (canceled)
39 . The method of claim 28 wherein the biliary disease is treated without removal of the gallbladder.
40 . The method of claim 28 wherein the biliary disease is treated without removal of the cystic duct.
41 . (canceled)
42 . The method of claim 28 further comprising the step of forming a biological duct in situ from a patient's tissue.
43 . The method of claim 28 further comprising the step of changing the cystic duct defunctionalizing device from a delivery configuration to a deployment configuration.
44 . The method of claim 28 further comprising the step of changing the cystic duct defunctionalizing device from a delivery configuration to a final configuration.
45 . The method of claim 28 further comprising the step of changing the cystic duct defunctionalizing device from a deployment configuration to a final configuration.
46 . The method of claim 28 further comprising the step of reducing a cross-sectional profile of the cystic duct defunctionalizing device.
47 . (canceled)
48 . The method of claim 28 further comprising the step of defunctionalizing the cystic duct in situ.
49 . The method of claim 48 wherein the step of defunctionalizing is achieved by delivering a substance into a space within the cystic duct.
50 . The method of claim 49 wherein the delivered substance is selected from the group consisting of gel and foam.
51 . The method of claim 49 further comprising the step of activating the delivered substance in situ.
52 . The method of claim 49 further comprising delivering an amount of substance sufficient to fill, or substantially fill, the cystic duct lumen.
53 . The method of claim 48 wherein the step of defunctionalizing is achieved by delivering a plug into a space within the cystic duct.
54 . The method of claim 53 wherein the plug is configurable either internally or externally to seat within the lumen.
55 . The method of claim 53 wherein the plug further comprises one or more thread profiles, ridges or steps about its exterior surface.
56 . (canceled)
57 . A kit for treating biliary disease comprising:
a. a device configurable to be positioned within a cystic duct; and optionally b. a compound for delivery to a tissue.
58 . (canceled)
59 . (canceled)
60 . (canceled)
61 . (canceled)
62 . (canceled)
63 . (canceled)
64 . (canceled)
65 . (canceled)
66 . A method of treating biliary disease comprising:
a. accessing a lumen associated with a gallbladder; b. defunctionalizing a cystic duct.
67 . (canceled)
68 . (canceled)
69 . (canceled)
70 . The method of claim 69 wherein the substance is one or more of antibiotics, inflammatory agents, and anti-inflammatory agents.
71 . The method of claim 66 further comprising the step of preventing bile from entering the gallbladder lumen.
72 . (canceled)
73 . The method of claim 66 further comprising the step of accessing the gallbladder via the gastrointestinal tract.
74 . The method of claim 73 wherein the step of accessing is performed in the gastrointestinal tract at a duodenum.
75 . The method of claim 73 wherein the step of defunctionalizing the cystic duct further comprises one or more of sclerosing, necrotizing or ablating tissue.
76 . The method of claim 75 wherein an ablation technique is selected from the group comprising cryoablation, thermal ablation, chemical ablation, radio frequency ablation, ultrasound ablation, and microwave ablation.
77 . The method of claim 73 further comprising the step of delivering a fluid with an angular orientation.
78 . The method of claim 73 further comprising the step of delivering a fluid with at least one of a 360 degree radial pattern, a sharp stream, and a cone shape.
79 . The method of claim 73 further comprising the step of delivering a fluid with a device comprising an articulating member.
80 . The method of claim 73 wherein the step of defunctionalizing the cystic duct further comprises applying a vacuum to a lumen of the cystic duct or the gallbladder.
81 . The method of claim 80 further comprising the step of applying all adhesive to the lumen of the cystic duct.
82 . (canceled)
83 . A device for treating biliary disease comprising a plug adapted and configurable to be positioned within a lumen of a cystic duct of a patient having a proximal end and a distal end and is configurable either internally or externally to seat within the lumen after deployment.
84 . The device of claim 83 wherein the external configuration is one or more of threads, ridges and steps.
85 . (canceled)
86 . (canceled)
87 . The device of claim 83 wherein the plug is positioned within or proximal to a cystic duct.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.